← Back to Genes

Genes Associated with Prostate Cancer

These genes are associated with prostate cancer risk—but having them doesn't determine your fate.

⚠️

Important context

These genes don't cause prostate cancer. They reveal which pathways might need extra support. Most men with these variants never develop prostate cancer. Environment, lifestyle, and metabolic health determine whether genetic risk becomes reality.

The genes.

Organized by function, not by how scary they sound.

DNA Repair

These genes help fix DNA damage. Variants can mean slower repair, not inevitable cancer.

BRCA1/BRCA2

Double-strand break repair

Often discussed with breast cancer, but also increases prostate cancer risk. Affects DNA repair capacity.

2-4x increased risk with BRCA2

ATM

DNA damage response

Senses DNA damage and coordinates repair. Variants slow the response, not eliminate it.

Moderate risk increase

CHEK2

Cell cycle checkpoint

Pauses cell division to allow repair. Variants may allow damaged cells to proceed.

1.5-2x increased risk

MSH2/MLH1

Mismatch repair (Lynch syndrome)

Fixes errors during DNA replication. Part of Lynch syndrome panel.

Increased colorectal and prostate risk

Hormone Metabolism

Prostate tissue is hormone-sensitive. These genes affect how hormones are made, used, and cleared.

AR

Androgen receptor

How prostate cells respond to testosterone and DHT. CAG repeat length affects sensitivity.

Shorter CAG repeats = higher sensitivity

SRD5A2

5-alpha reductase

Converts testosterone to DHT. DHT is more potent in prostate tissue.

Variants affect DHT production

CYP17A1

Steroid hormone synthesis

Key enzyme in making androgens. Affects overall hormone levels.

Influences androgen production

Detoxification

These genes help clear toxins and metabolize compounds. Slower clearance = longer exposure.

GSTP1

Glutathione conjugation

Detoxifies carcinogens. Often silenced (methylated) in prostate cancer tissue.

Silencing is an early event in many prostate cancers

CYP1B1

Estrogen and toxin metabolism

Metabolizes estrogens and environmental toxins. Some metabolites are more harmful.

Variants affect metabolite profiles

Vitamin D & Immune

Vitamin D signaling affects cell growth and immune function in prostate tissue.

VDR

Vitamin D receptor

How cells respond to vitamin D. Affects growth regulation and immune function.

Some variants associated with risk, especially with low vitamin D

Prostate Development

Genes specifically involved in prostate tissue development and maintenance.

HOXB13

Prostate development

Transcription factor for prostate development. G84E variant is a known risk factor.

G84E: 3-5x increased risk (rare variant)

What actually matters.

Genes load the gun. Environment pulls the trigger. Here's what modifies genetic risk.

🔥

Inflammation

Chronic prostate inflammation (prostatitis) is a consistent risk factor. Diet, infections, and lifestyle all contribute.

⚖️

Hormone Balance

It's not just testosterone—the ratio of testosterone to estrogen, DHT levels, and hormone metabolism all matter.

📊

Insulin & Metabolic Health

Insulin resistance and metabolic syndrome are associated with more aggressive prostate cancer.

☀️

Vitamin D Status

Low vitamin D is consistently associated with higher risk. VDR variants matter more when vitamin D is low.

🛡️

Oxidative Stress

The prostate is vulnerable to oxidative damage. Antioxidant capacity affects tissue health.

🥦

Diet & Lifestyle

Cruciferous vegetables, lycopene, omega-3s, and physical activity all influence risk through multiple pathways.

"Genes don't cause prostate cancer. They show which pathways need support to prevent it."
← Back to all genes